Aktiesnakken — Oktober 2018
-
God morgen
-
-
this Ofatumumab Mantle Cell Lymphoma trial is extended by 1 year https://clinicaltrials.gov/ct2/history/NCT01437709?A=18&B=19&C=merged
-
idom..Kan ikke sige så meget mere end Henrik gør i videoen. Lau og jeg snakker også om den i dagens Mio-klub.
-
God morgen
-
Hvis nogle skulle være interesserede i et job med garanteret fokus fra ledelsen
https://www.danskebank.com/da-dk/karriere/soeg-job/Pages/JobShow.aspx?JobPostingId=15666 -
Teknisk videoopdatering på Genmab. Nove, Ambu og Zealand Pharma: http://www.proinvestor.com/debat/76287
-
-
-
Investormøde – mød Scandion Oncology
Ny aktie på Spotlight Stock Market bekæmper resistens mod kemoterapi
(www.anpdm.com)
-
God morgen
-
Teknisk update: Ambu, Veloxis, Bioporto og Bavarian: http://www.proinvestor.com/debat/76299
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind